These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7176279)

  • 1. [Measurements of urinary macromolecular inhibitory activity of calcium oxalate crystal aggregation].
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Nihon Hinyokika Gakkai Zasshi; 1982 May; 73(5):644-51. PubMed ID: 7176279
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation.
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer].
    Ebisuno S; Miyata K; Kohjimoto Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):339-44. PubMed ID: 8464186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary crystal surface binding substances on calcium oxalate crystals.
    Koide T; Yoshioka T; Yamaguchi S; Hosokawa S; Utsunomiya M; Sonoda T
    Urol Res; 1990; 18(6):387-92. PubMed ID: 2100413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characterization of urinary macromolecular inhibitors of calcium oxalate crystal aggregation].
    Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T
    Nihon Hinyokika Gakkai Zasshi; 1982 May; 73(5):652-7. PubMed ID: 6184514
    [No Abstract]   [Full Text] [Related]  

  • 6. An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine.
    Sørensen S; Hansen K; Bak S; Justesen SJ
    Urol Res; 1990; 18(6):373-9. PubMed ID: 2100411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uromucoids and urinary stone formation.
    Hallson PC; Rose GA
    Lancet; 1979 May; 1(8124):1000-2. PubMed ID: 86719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of urinary material and glycosaminoglycans on calcium oxalate monohydrate crystal aggregation].
    Shirane Y; Yamamoto A; Mizuta K; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1000-3. PubMed ID: 2514310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macromolecular inhibitors of calcium oxalate crystal growth and aggregation.
    Brockis JG; Bowyer RC; McCulloch RK
    Scand J Urol Nephrol Suppl; 1980; 53():67-74. PubMed ID: 6938008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
    Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A
    Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
    Khan SR
    Scanning Microsc; 1995 Jun; 9(2):597-614; discussion 614-6. PubMed ID: 8714752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.
    Drach GW; Thorson S; Randolph A
    J Urol; 1980 Apr; 123(4):519-23. PubMed ID: 7365890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers.
    Wesson JA; Ganne V; Beshensky AM; Kleinman JG
    Urol Res; 2005 Jun; 33(3):206-12. PubMed ID: 15864572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
    Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A
    Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton.
    Erwin DT; Kok DJ; Alam J; Vaughn J; Coker O; Carriere BT; Lindberg J; Husserl FE; Fuselier H; Cole FE
    Am J Kidney Dis; 1994 Dec; 24(6):893-900. PubMed ID: 7985666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers.
    Kumar V; Peña de la Vega L; Farell G; Lieske JC
    Kidney Int; 2005 Oct; 68(4):1784-92. PubMed ID: 16164655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary inhibitory activity of calcium oxalate monohydrate crystal growth in stone-formers & non stone-formers.
    Sidhu H; Vaidyanathan S; Wangoo D; Rattan V; Thind SK; Nath R; Malakondaiah GC; Tandon SP
    Indian J Med Res; 1987 Oct; 86():500-5. PubMed ID: 3443483
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of urine on "in vitro" crystallization rate of calcium oxalate: determination of inhibitory activity by a [14C]oxalate technique.
    Ligabue A; Fini M; Robertson WG
    Clin Chim Acta; 1979 Oct; 98(1-2):39-46. PubMed ID: 227625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
    Gjaldbaek JC; Robertson WG
    Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.